Community reviews

Community reviews for biocentury.com

No approved reviews for biocentury.com yet. Be the first to share your experience. See the independent website safety report.

Reviews do not change the independent technical Safety Score.

Write review →Review biocentury.com

You need an account and verified email to post. Create a free account.

About biocentury.com

CoRegen is preparing to dose its first patients with an autologous, CRISPR-edited regulatory T cell (Treg) therapy after clearing an IND last month. The biotech is betting that knocking out a single gene can reverse the role Tregs normally play in suppressing immune responses, preventing tumors from using the cells to evade immune attack.

Screenshot of biocentury.com from the current report — Website screenshot from the current report

See website report →

Community rating— / 5☆☆☆☆☆(0 approved reviews)

ModerationActiveSubmissions are checked before publication

Independent assessmentSeparateVisitor opinions never change the Safety Score

Manually moderated

Reviews (0)

Approved reviews only, newest first. Each submission is held for moderation.

Write review

No approved reviews yet

Be the first to share your experience with biocentury.com.

Write review →